早幼粒細胞白血病蛋白
位於15號人類染色體的基因
早幼粒細胞白血病蛋白是指可能的轉錄因子可能的轉錄因子(英語:Probable transcription factor PML),是一個由人類基因 PML 編碼的抑癌蛋白。
功能
互作
早幼粒細胞白血病蛋白可與下列蛋白質發生交互作用:
- ANKRD2,[1]
- CREB-binding protein,[2][3][4]
- Cyclin T1,[5]
- Death associated protein 6,[6][7][8][9]
- GATA2,[10]
- HDAC1,[11][12]
- HDAC3,[12]
- HHEX,[13]
- MAPK11,[14]
- MYB,[15]
- Mdm2,[16][17][18][19]
- Nerve Growth factor IB,[20]
- Nuclear receptor co-repressor 1,[11]
- Nuclear receptor co-repressor 2,[11][21]
- P53,[16][22][23]
- RPL11,[17]
- 視網膜母細胞瘤蛋白[24]
- 視黃酸受體α,[2]
- SIN3A,[11]
- SKI protein,[11]
- STAT3,[25]
- Serum response factor[3]and
- Small ubiquitin-related modifier 1,[26][27]
- Sp1 transcription factor,[28]
- TOPBP1,[29]
- Thymine-DNA glycosylase,[30]and
- Zinc finger and BTB domain-containing protein 16.[31]
參見
參考文獻
- ^ Kojic, Snezana; Medeot, Elisa; Guccione, Ernesto; Krmac, Helena; Zara, Ivano; Martinelli, Valentina; Valle, Giorgio; Faulkner, Georgine. The Ankrd2 Protein, a Link Between the Sarcomere and the Nucleus in Skeletal Muscle. Journal of Molecular Biology. 2004-05, 339 (2) [2022-06-16]. doi:10.1016/j.jmb.2004.03.071. (原始內容存檔於2022-06-15) (英語).
- ^ 2.0 2.1 Zhong, Sue; Delva, Laurent; Rachez, Christophe; Cenciarelli, Cristina; Gandini, Domenica; Zhang, Hui; Kalantry, Sundeep; Freedman, Leonard P.; Pandolfi, Pier Paolo. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARα and T18 oncoproteins. Nature Genetics. 1999-11, 23 (3) [2022-06-16]. ISSN 1061-4036. PMID 10610177. doi:10.1038/15463. (原始內容存檔於2022-03-10) (英語).
- ^ 3.0 3.1 Matsuzaki, Kazuhito; Minami, Takeshi; Tojo, Masahide; Honda, Yoshiomi; Saitoh, Noriko; Nagahiro, Shinji; Saya, Hideyuki; Nakao, Mitsuyoshi. PML-nuclear bodies are involved in cellular serum response. Genes to Cells: Devoted to Molecular & Cellular Mechanisms. 2003-03, 8 (3) [2022-06-16]. ISSN 1356-9597. PMID 12622724. doi:10.1046/j.1365-2443.2003.00632.x. (原始內容存檔於2022-06-16).
- ^ Doucas, Vassilis; Tini, Marc; Egan, David A.; Evans, Ronald M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proceedings of the National Academy of Sciences. 1999-03-16, 96 (6) [2022-06-16]. ISSN 0027-8424. PMC 15819 . PMID 10077561. doi:10.1073/pnas.96.6.2627. (原始內容存檔於2022-06-16) (英語).
- ^ Marcello, A. Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. The EMBO Journal. 2003-05-01, 22 (9). PMC 156077 . PMID 12727882. doi:10.1093/emboj/cdg205.
- ^ Ishov, Alexander M.; Sotnikov, Alexey G.; Negorev, Dmitri; Vladimirova, Olga V.; Neff, Norma; Kamitani, Tetsu; Yeh, Edward T.H.; Strauss, Jerome F.; Maul, Gerd G. Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1. Journal of Cell Biology. 1999-10-18, 147 (2) [2022-06-16]. ISSN 0021-9525. PMC 2174231 . PMID 10525530. doi:10.1083/jcb.147.2.221. (原始內容存檔於2022-06-16) (英語).
- ^ Li, Hui; Leo, Christopher; Zhu, Jiang; Wu, Xiaoyang; O'Neil, Jennifer; Park, Eun-Ju; Chen, J. Don. Sequestration and Inhibition of Daxx-Mediated Transcriptional Repression by PML. Molecular and Cellular Biology. 2000-03, 20 (5) [2022-06-16]. ISSN 0270-7306. PMC 85360 . PMID 10669754. doi:10.1128/MCB.20.5.1784-1796.2000. (原始內容存檔於2021-11-28) (英語).
- ^ Lehembre, François; Müller, Stefan; Pandolfi, Pier Paolo; Dejean, Anne. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML. Oncogene. 2001-01-04, 20 (1) [2022-06-16]. ISSN 0950-9232. PMID 11244500. doi:10.1038/sj.onc.1204063. (原始內容存檔於2021-08-11) (英語).
- ^ Zhong, Sue; Salomoni, Paolo; Ronchetti, Simona; Guo, Ailan; Ruggero, Davide; Pandolfi, Pier Paolo. Promyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway for Apoptosis. Journal of Experimental Medicine. 2000-02-21, 191 (4) [2022-06-16]. ISSN 0022-1007. PMC 2195846 . PMID 10684855. doi:10.1084/jem.191.4.631. (原始內容存檔於2022-06-16) (英語).
- ^ Tsuzuki, Shinobu; Towatari, Masayuki; Saito, Hidehiko; Enver, Tariq. Potentiation of GATA-2 Activity through Interactions with the Promyelocytic Leukemia Protein (PML) and the t(15;17)-Generated PML-Retinoic Acid Receptor α Oncoprotein. Molecular and Cellular Biology. 2000-09, 20 (17) [2022-06-16]. ISSN 0270-7306. PMC 86102 . PMID 10938104. doi:10.1128/MCB.20.17.6276-6286.2000. (原始內容存檔於2022-06-16) (英語).
- ^ 11.0 11.1 11.2 11.3 11.4 Khan, M. M.; Nomura, T.; Kim, H.; Kaul, S. C.; Wadhwa, R.; Shinagawa, T.; Ichikawa-Iwata, E.; Zhong, S.; Pandolfi, P. P.; Ishii, S. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. Molecular Cell. 2001-06, 7 (6) [2022-06-16]. ISSN 1097-2765. PMID 11430826. doi:10.1016/s1097-2765(01)00257-x. (原始內容存檔於2021-11-28).
- ^ 12.0 12.1 Wu, Wen-Shu; Vallian, Sadeq; Seto, Edward; Yang, Wen-Ming; Edmondson, Diane; Roth, Sharon; Chang, Kun-Sang. The Growth Suppressor PML Represses Transcription by Functionally and Physically Interacting with Histone Deacetylases. Molecular and Cellular Biology. 2001-04, 21 (7) [2022-06-16]. ISSN 0270-7306. PMC 86860 . PMID 11259576. doi:10.1128/MCB.21.7.2259-2268.2001. (原始內容存檔於2022-06-16) (英語).
- ^ Topcu, Zeki; Mack, David L; Hromas, Robert A; Borden, Katherine LB. The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control. Oncogene. 1999-11-25, 18 (50) [2022-06-16]. ISSN 0950-9232. PMID 10597310. doi:10.1038/sj.onc.1203201. (原始內容存檔於2022-06-16) (英語).
- ^ Shin, Jinwook; Park, Boyoun; Cho, Sunglim; Lee, Sunray; Kim, Youngkyun; Lee, Seong-Ok; Cho, Kwangmin; Lee, Sungwook; Jin, Bong-Suk; Ahn, Jin-Hyun; Choi, Eui-Ju. Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase. The Journal of Biological Chemistry. 2004-09-24, 279 (39) [2022-06-16]. ISSN 0021-9258. PMID 15273249. doi:10.1074/jbc.M407369200. (原始內容存檔於2022-06-16).
- ^ Dahle, Øyvind; Bakke, Oddmund; Gabrielsen, Odd Stokke. c-Myb associates with PML in nuclear bodies in hematopoietic cells. Experimental Cell Research. 2004-07-01, 297 (1) [2022-06-16]. ISSN 0014-4827. PMID 15194430. doi:10.1016/j.yexcr.2004.03.014. (原始內容存檔於2022-06-16).
- ^ 16.0 16.1 Kurki, Sari; Latonen, Leena; Laiho, Marikki. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization. Journal of Cell Science. 2003-10-01, 116 (19) [2022-06-16]. ISSN 1477-9137. PMID 12915590. doi:10.1242/jcs.00714. (原始內容存檔於2022-06-16) (英語).
- ^ 17.0 17.1 Bernardi, Rosa; Scaglioni, Pier Paolo; Bergmann, Stephan; Horn, Henning F.; Vousden, Karen H.; Pandolfi, Pier Paolo. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nature Cell Biology. 2004-07, 6 (7) [2022-06-16]. ISSN 1465-7392. PMID 15195100. doi:10.1038/ncb1147. (原始內容存檔於2022-06-17) (英語).
- ^ Zhu, Hongyan; Wu, Liqing; Maki, Carl G. MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53. The Journal of Biological Chemistry. 2003-12-05, 278 (49) [2022-06-16]. ISSN 0021-9258. PMID 14507915. doi:10.1074/jbc.M308302200. (原始內容存檔於2022-06-16).
- ^ Wei, Xiaolong; Yu, Zhong Kang; Ramalingam, Arivudainambi; Grossman, Steven R.; Yu, Jiang H.; Bloch, Donald B.; Maki, Carl G. Physical and functional interactions between PML and MDM2. The Journal of Biological Chemistry. 2003-08-01, 278 (31) [2022-06-16]. ISSN 0021-9258. PMID 12759344. doi:10.1074/jbc.M212215200. (原始內容存檔於2022-06-16).
- ^ Wu, Wen-Shu; Xu, Zhi-Xiang; Ran, Ruixiang; Meng, Feng; Chang, Kun-Sang. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Oncogene. 2002-05-30, 21 (24) [2022-06-16]. ISSN 0950-9232. PMID 12032831. doi:10.1038/sj.onc.1205491. (原始內容存檔於2022-06-16) (英語).
- ^ Hong, Suk-Hyun; Yang, Zhihong; Privalsky, Martin L. Arsenic Trioxide Is a Potent Inhibitor of the Interaction of SMRT Corepressor with Its Transcription Factor Partners, Including the PML-Retinoic Acid Receptor α Oncoprotein Found in Human Acute Promyelocytic Leukemia. Molecular and Cellular Biology. 2001-11, 21 (21) [2022-06-16]. ISSN 0270-7306. PMC 99892 . PMID 11585900. doi:10.1128/MCB.21.21.7172-7182.2001. (原始內容存檔於2021-08-11) (英語).
- ^ Fogal, V. Regulation of p53 activity in nuclear bodies by a specific PML isoform. The EMBO Journal. 2000-11-15, 19 (22). PMC 305840 . PMID 11080164. doi:10.1093/emboj/19.22.6185.
- ^ Guo, Ailan; Salomoni, Paolo; Luo, Jianyuan; Shih, Alan; Zhong, Sue; Gu, Wei; Paolo Pandolfi, Pier. The function of PML in p53-dependent apoptosis. Nature Cell Biology. 2000-10, 2 (10) [2022-06-16]. ISSN 1465-7392. PMID 11025664. doi:10.1038/35036365. (原始內容存檔於2022-06-16) (英語).
- ^ Alcalay, Myriam; Tomassoni, Lucia; Colombo, Emanuela; Stoldt, Stephan; Grignani, Francesco; Fagioli, Marta; Szekely, Laszlo; Helin, Kristian; Pelicci, Pier Giuseppe. The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein. Molecular and Cellular Biology. 1998-02, 18 (2) [2022-06-16]. ISSN 0270-7306. PMC 108821 . PMID 9448006. doi:10.1128/MCB.18.2.1084. (原始內容存檔於2022-06-16) (英語).
- ^ Kawasaki, Akira; Matsumura, Itaru; Kataoka, Yoshihisa; Takigawa, Eri; Nakajima, Koichi; Kanakura, Yuzuru. Opposing effects of PML and PML/RARα on STAT3 activity. Blood. 2003-05-01, 101 (9) [2022-06-16]. ISSN 1528-0020. PMID 12506013. doi:10.1182/blood-2002-08-2474. (原始內容存檔於2022-06-16) (英語).
- ^ Lin, Ding-Yen; Shih, Hsiu-Ming. Essential role of the 58-kDa microspherule protein in the modulation of Daxx-dependent transcriptional repression as revealed by nucleolar sequestration. The Journal of Biological Chemistry. 2002-07-12, 277 (28) [2022-06-16]. ISSN 0021-9258. PMID 11948183. doi:10.1074/jbc.M200633200. (原始內容存檔於2022-06-20).
- ^ Kamitani, T.; Nguyen, H. P.; Kito, K.; Fukuda-Kamitani, T.; Yeh, E. T. Covalent modification of PML by the sentrin family of ubiquitin-like proteins. The Journal of Biological Chemistry. 1998-02-06, 273 (6) [2022-06-16]. ISSN 0021-9258. PMID 9452416. doi:10.1074/jbc.273.6.3117. (原始內容存檔於2022-06-20).
- ^ Vallian, Sadeq; Chin, Khew-Voon; Chang, Kun-Sang. The Promyelocytic Leukemia Protein Interacts with Sp1 and Inhibits Its Transactivation of the Epidermal Growth Factor Receptor Promoter. Molecular and Cellular Biology. 1998-12, 18 (12) [2022-06-16]. ISSN 0270-7306. PMC 109296 . PMID 9819401. doi:10.1128/MCB.18.12.7147. (原始內容存檔於2022-06-16) (英語).
- ^ Xu, Zhi-Xiang; Timanova-Atanasova, Anna; Zhao, Rui-Xun; Chang, Kun-Sang. PML Colocalizes with and Stabilizes the DNA Damage Response Protein TopBP1. Molecular and Cellular Biology. 2003-06-15, 23 (12). ISSN 0270-7306. PMC 156140 . PMID 12773567. doi:10.1128/MCB.23.12.4247-4256.2003 (英語).
- ^ Takahashi, Hidehisa; Hatakeyama, Shigetsugu; Saitoh, Hisato; Nakayama, Keiichi I. Noncovalent SUMO-1 binding activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein. The Journal of Biological Chemistry. 2005-02-18, 280 (7) [2022-06-16]. ISSN 0021-9258. PMID 15569683. doi:10.1074/jbc.M408130200. (原始內容存檔於2022-06-16).
- ^ Koken, M. H. M.; Reid, A.; Quignon, F.; Chelbi-Alix, M. K.; Davies, J. M.; Kabarowski, J. H. S.; Zhu, J.; Dong, S.; Chen, S.-J.; Chen, Z.; Tan, C. C. Leukemia-associated retinoic acid receptor α fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proceedings of the National Academy of Sciences. 1997-09-16, 94 (19) [2022-06-16]. ISSN 0027-8424. PMC 23349 . PMID 9294197. doi:10.1073/pnas.94.19.10255. (原始內容存檔於2022-06-16) (英語).
延伸閱讀
- Zhong, Sue; Salomoni, Paolo; Pandolfi, Pier Paolo. The transcriptional role of PML and the nuclear body. Nature Cell Biology. 2000-05, 2 (5) [2022-06-16]. ISSN 1465-7392. PMID 10806494. doi:10.1038/35010583. (原始內容存檔於2022-03-10) (英語).
- Jensen, Kirsten; Shiels, Carol; Freemont, Paul S. PML protein isoforms and the RBCC/TRIM motif. Oncogene. 2001-10-29, 20 (49) [2022-06-16]. ISSN 0950-9232. PMID 11704850. doi:10.1038/sj.onc.1204765. (原始內容存檔於2022-05-25) (英語).
- Pearson, Mark; Pelicci, Pier Giuseppe. PML interaction with p53 and its role in apoptosis and replicative senescence. Oncogene. 2001-10-29, 20 (49) [2022-06-16]. ISSN 0950-9232. PMID 11704853. doi:10.1038/sj.onc.1204856. (原始內容存檔於2022-06-16) (英語).>
- Salomoni, Paolo; Pandolfi, Pier Paolo. The role of PML in tumor suppression. Cell. 2002-01-25, 108 (2) [2022-06-16]. ISSN 0092-8674. PMID 11832207. doi:10.1016/s0092-8674(02)00626-8. (原始內容存檔於2022-03-02).
- Combes, Robert; Balls, Michael; Bansil, Lee; Barratt, Martin; Bell, David; Botham, Phil; Broadhead, Caren; Clothier, Richard; George, Elizabeth; Fentem, Julia; Jackson, Michael. An Assessment of Progress in the Use of Alternatives in Toxicity Testing since the Publication of the Report of the Second FRAME Toxicity Committee (1991). Alternatives to Laboratory Animals. 2002-07, 30 (4) [2022-06-16]. ISSN 0261-1929. PMID 12234245. doi:10.1177/026119290203000403. (原始內容存檔於2021-08-10) (英語).
- Bernardi, Rosa; Pandolfi, Pier Paolo. Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene. 2003-12-08, 22 (56) [2022-06-16]. ISSN 0950-9232. PMID 14663483. doi:10.1038/sj.onc.1207106. (原始內容存檔於2022-06-16) (英語).
- Beez, Sabine; Demmer, Philipp; Puccetti, Elena. Tse, William , 編. Targeting the Acute Promyelocytic Leukemia-Associated Fusion Proteins PML/RARα and PLZF/RARα with Interfering Peptides. PLoS ONE. 2012-11-09, 7 (11). ISSN 1932-6203. PMC 3494703 . PMID 23152790. doi:10.1371/journal.pone.0048636 (英語).